Sciton®, a leading manufacturer of high-quality laser and light systems in the medical market, will unveil a new and improved Halo Hybrid Fractional Laser at the 38th Annual Conference of the American Society for Laser Medicine and Surgery, April 11 – 15th, at the Hilton Anatole in Dallas, TX. “Halo has generated tremendous buzz with its ideal combination of great results and low downtime and these enhancements will make Halo even more phenomenal,” says Rick Mendez, Vice President of Global Marketing for Sciton.
This years program will also highlight a variety of Sciton’s other laser modules as well, with over 15 podium mentions from 10 of their esteemed luminaries including: Dr. Jason Pozner, Dr. Jill Waibel, Dr. Matthew Avram, Dr. Joel Cohen, and more.
Visit Sciton at booth #207 to learn more about the new Halo features including Tempo technology which helps ensure even treatment; new state of the art software templates for off-face treatments; ABM (Adjustable Beam Placement) technology to treat areas with distinct edges or smaller zones; and Customizable Pass Selection which puts the practitioner in control of the treatment speed and energy density.
Sciton will hold expert sessions, during exhibit hours, for individuals curious about what Sciton products can mean for the future of their practice. Sciton’s experienced line-up of speakers will be accessible at booth 207 to share their insights and experience. “I look forward to sharing my many years of experience on Sciton technology during the Meet Expert Sessions at ASLMS — particularly heavy full-field erbium resurfacing for severe etched lines on the upper lip,” said Dermatologist Joel Cohen, MD.
Sciton will also host a technology-focused strategic advisory board meeting at ASLMS which will take place on Thursday, April 12th. “The insights we gain from these meetings are extremely important to Sciton’s future as we turn to our key opinion leaders for guidance regarding industry trends, needs, and expectations,” said Jim Hobart, Sciton’s CEO. Among the topics to be discussed will be the company’s recent partnership with diagnostic imaging technology, VivoSight OCT, and the future of women’s health.